GOVX - Total Utang marang Modal GeoVax Corp
GeoVax Labs, Inc. (GOVX) operations center on developing antiviral drugs within a closed environment, where funding and success depend on FDA approval and BARDA contracts. Market capitalization relies on government procurement and WHO grants for the development of anti-cancer vaccines. This chart illustrates a total debt-to-equity market valuation of 0.19, while MVA platform patents and lobbying efforts protect the business from new entrants.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_GOVX_-_GeoVax-Labs-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "GOVX (GeoVax Labs, Inc.) riwayat Total Utang marang Modal saka 04.07.2022 nganti 31.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan GeoVax Labs, Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas GeoVax Labs, Inc.|GOVX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal GeoVax Labs, Inc.|GOVX - Gunggung utang perusahaan|Utang marang nilai buku GeoVax|GOVX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan GeoVax|Likuiditas cepet geovax.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:GeoVax
Investors assess the financial stability of an asset through the total liabilities-to-equity ratio, which determines the business's degree of dependence on borrowed funds. By analyzing the historical debt-to-equity ratio, one can understand the extent to which GeoVax Labs, Inc. (GOVX) is capable of financing the development of oncology vaccines and the GV-MVA-VLP platform without a critical debt load that would diminish investment attractiveness while awaiting clinical trial data.
Analisis pesaing GeoVax Labs, Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Rasio Utang marang Modal Savara Pharma (SVRA)|RIGL: Total Utang marang Modal|Utang marang Modal anaptysbio.com (ANAB)|Utang marang Ekuitas Astria Therapeutics, Inc.|Utang marang Modal enGene Holdings Inc ENGN|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|Utang marang Ekuitas JBIO (aerovatetx.com)|Total Utang marang Modal ACRS (Aclaris Therapeutics)|Total Utang marang Modal kyvernatx.com KYTX|TLSA: Rasio Total Utang marang Ekuitas|CABA (Cabaletta Bio Inc.) - Rasio Utang marang Ekuitas|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Avalo Therapeutics, Inc|Utang marang Ekuitas ELDN|Total Utang marang Modal AGEN|Total Utang marang Modal Climb Bio Inc. (CLYM)|Total Utang marang Modal ZURA (Zura Bio Limited)|aTyr Pharmaceuticals - Utang marang Ekuitas|ADAG - Utang marang Ekuitas|Koefisien Total Utang marang Modal ImageneBio Inc IMA|STTK (shattucklabs.com) - Rasio Total Utang marang Ekuitas|Equillium - Rasio Kabeh Utang marang Dana Pribadi|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Immunic Inc (IMUX) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Atara Biotherapeutics (ATRA)|inflarx.de - Rasio Utang marang Ekuitas|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|ACET - Rasio Total Utang marang Ekuitas|CELU: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal INmune Bio Corporation INMB|BRNS: Total Utang marang Modal|Rasio Utang marang Modal kezarlifesciences.com KZR|Utang marang Ekuitas SAB Biotherapeutics, Inc.|Utang marang Modal Akari Therapeutics PLC AKTX|Rasio Total Utang marang Ekuitas ENLV (Enlivex Therapeutics)|Utang marang Ekuitas QTTB (q32bio.com)|Edesa Biotech, Inc. - Rasio Total Utang marang Ekuitas|IBIO: Rasio Utang marang Ekuitas|CARM - Utang marang Ekuitas|Utang Agregat marang Ekuitas XTLB|BOLT: Total Utang marang Modal|HCW Biologics - Rasio Kabeh Utang marang Dana Pribadi|APVO (Aptevo Therapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal AIM ImmunoTech, Inc.|Utang marang Ekuitas Aditxt (ADTX)|GRI (GRI Bio Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas XORTX XRTX|HIND - Rasio Total Utang marang Ekuitas|Revelation Biosciences - Total Utang marang Modal|INDP - Total Utang marang Modal|SCNI (Scinai Immunotherapeutics Ltd.) - Rasio Total Utang marang Ekuitas|CalciMedica - Rasio Kabeh Utang marang Dana Pribadi|AFMD (Affimed NV) - Total Utang marang Modal|Allakos Therapeutics (ALLK) - Koefisien Total Utang marang Modal|Utang marang Ekuitas HOOKIPA Pharma Inc. (HOOK)|Rasio Total Utang marang Ekuitas igmbio.com IGMS|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|OCEA - Rasio Total Utang marang Ekuitas|TCBP: Rasio Total Utang marang Ekuitas|THRD - Total Utang marang Modal